Cambridge, MA, United States of America

G-Yoon Jamie Im

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 11.4

ph-index = 5

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):

Title: **Inventor Profile: G-Yoon Jamie Im**

Introduction

G-Yoon Jamie Im, based in Cambridge, MA, is a prominent inventor known for his contributions to pharmaceutical innovations. With an impressive portfolio comprising 12 patents, his work primarily focuses on therapeutics addressing critical health conditions.

Latest Patents

Among his latest inventions, G-Yoon Jamie Im has developed methods and compositions involving sGC stimulators for treating nonalcoholic steatohepatitis (NASH). His patent outlines the use of these stimulators, particularly NO-independent and heme-dependent ones, aimed at effectively treating, preventing, or managing disorders related to NASH. The detailed disclosure includes pharmaceutical compositions and kits that facilitate this innovative approach.

Career Highlights

Throughout his career, G-Yoon Jamie Im has made significant strides in the pharmaceutical landscape. He has worked with renowned companies such as Cyclerion Therapeutics, Inc. and Ironwood Pharmaceuticals, Inc., contributing to the development of novel therapeutic agents and innovative drug delivery systems.

Collaborations

G-Yoon Jamie Im has collaborated with notable professionals in his field, including Rajesh R Iyengar and Paul A Renhowe. These partnerships have propelled advancements in pharmacology and therapeutic research, enhancing the impact of his inventions.

Conclusion

G-Yoon Jamie Im stands out as a talented inventor whose work is pivotal in addressing complex medical conditions like NASH. His patents not only signify individual achievement but also contribute to the broader landscape of pharmaceutical innovations, promising new avenues for treatment and enhanced patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…